Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mesoblast Limited (MEOBF)
OTHER OTC:MEOBF
Holding MEOBF?
Track your performance easily
MEOBF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.10 - $1.12
Previous Close$1.03
Volume10.00K
Average Volume (3M)524.00
Market Cap
$1.19B
Enterprise Value$1.25B
Total Cash (Recent Filing)$63.18M
Total Debt (Recent Filing)$118.92M
Price to Earnings (P/E)―
Beta1.45
Next Earnings
Feb 20, 2025EPS Estimate
-$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding736,578,315
10 Day Avg. Volume2,450
30 Day Avg. Volume524
Standard Deviation0.30
R-Squared0.06
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)0.25
Price to Sales (P/S)24.95
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue364.80
Enterprise Value/Gross Profit211.58
Enterprise Value/Ebitda-41.83
Forecast
1Y Price Target
$0.81Price Target Upside-22.86% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Mesoblast Limited News
PremiumCompany Announcements
JPMorgan Chase Takes Significant Stake in Mesoblast
PremiumCompany Announcements
Mesoblast Limited’s AGM Resolutions Gain Strong Approval
PremiumCompany Announcements
Mesoblast Director Joseph Swedish Steps Down
PremiumCompany Announcements
Mesoblast Limited Outlines Future Strategies and Growth Prospects
PremiumCompany Announcements
Mesoblast Limited Advances in Drug Development and CommercializationPremiumCompany Announcements
Mesoblast Limited Issues Unquoted Warrants in Strategic Move
PremiumCompany Announcements
Mesoblast Issues Warrants in $50 Million AgreementOwnership Overview
7.10% Insiders
2.61% Mutual Funds
0.01% Other Institutional Investors
87.77% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MEOBF FAQ
What was Mesoblast Limited’s price range in the past 12 months?
Mesoblast Limited lowest stock price was $0.10 and its highest was $1.12 in the past 12 months.
What is Mesoblast Limited’s market cap?
Currently, no data Available
When is Mesoblast Limited’s upcoming earnings report date?
Mesoblast Limited’s upcoming earnings report date is Feb 20, 2025 which is in 90 days.
How were Mesoblast Limited’s earnings last quarter?
Currently, no data Available
Is Mesoblast Limited overvalued?
According to Wall Street analysts Mesoblast Limited’s price is currently Overvalued.
Does Mesoblast Limited pay dividends?
Mesoblast Limited does not currently pay dividends.
What is Mesoblast Limited’s EPS estimate?
Mesoblast Limited’s EPS estimate is -$0.04.
How many shares outstanding does Mesoblast Limited have?
Mesoblast Limited has 1,141,784,000 shares outstanding.
What happened to Mesoblast Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mesoblast Limited?
Currently, no hedge funds are holding shares in MEOBF
---
Mesoblast Limited Stock Smart Score
Company Description
Mesoblast Limited
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.
---
MEOBF Company Deck
---
MEOBF Earnings Call
Q4 2024
0:00 / 0:00
---
MEOBF Stock 12 Month Forecast
Average Price Target
$0.81
▼(-22.86% Downside)
Technical Analysis
Best Analysts Covering MEOBF
1 Year
1 Year Success Rate
2/7 ratings generated profit
1 Year Average Return
-22.66%
reiterated a buy rating 3 months ago
Copying John Hester's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -22.66% per trade.
---